Breed-independent toll-like receptor 5 polymorphisms show association with canine inflammatory bowel disease

Tissue Antigens

Volumn 78, Issue 2, 2011, Pages 94-101

  Kathrani, A ^a   House, A ^a   Catchpole, B ^a   Murphy, A ^a   Werling, D ^a   Allenspach, K ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Breeds; Canine; Inflammatory bowel disease; Polymorphisms; Toll like receptor

Indexed keywords

EDETIC ACID; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREEDING LINE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA EXTRACTION; ENTERITIS; EXPERIMENTAL DOG; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; CASE-CONTROL STUDIES; DNA; DOGS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; INFLAMMATORY BOWEL DISEASES; MALE; POLYMORPHISM, GENETIC; SPECIES SPECIFICITY; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 5;

CANIS FAMILIARIS;

EID: 79960010251     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01707.x     Document Type: Article

References (39)

1. Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol 2005: 174: 4453-60.
2. Magalhaes JG, Tattoli I, Girardin SE. The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens. Semin Immunol 2007: 19: 106-15.
3. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004: 118: 229-41.
4. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007: 448: 427-34.
5. Jergens AE, Moore FM, Haynes JS, Miles KG. Idiopathic inflammatory bowel disease in dogs and cats: 84 cases (1987-1990). J Am Vet Med Assoc 1992: 201: 1603-8.
6. Allenspach K, Wieland B, Grone A, Gaschen F. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med 2007: 21: 700-8.
7. Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999: 11: 648-56.
8. Fritz JH, Le Bourhis L, Magalhaes JG, Philpott DJ. Innate immune recognition at the epithelial barrier drives adaptive immunity: APCs take the back seat. Trends Immunol 2008: 29: 41-9.
9. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002: 15: 79-94.
10. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001: 411: 599-603.
11. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001: 411: 603-6.
12. Pierik M, Joossens S, Van Steen K et al. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 2006: 12: 1-8.
13. Browning BL, Huebner C, Petermann I et al. Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterol 2007: 102: 2504-12.
14. Gewirtz AT, Vijay-Kumar M, Brant SR, Duerr RH, Nicolae DL, Cho JH. Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2006: 290: G1157-63.
15. Kathrani A, House A, Catchpole B et al. Polymorphisms in the TLR4 and TLR5 gene are significantly associated with inflammatory bowel disease in German Shepherd dogs. PLoS One 2010: 5: e15740.
16. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992: 48: 361-72.
17. Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006: 22: 1928-9.
18. Schwarz G. Estimating the dimension of a model. Annu Stat 1978: 6: 461-4.
19. Akaike H. A new look at the statistical model identification. IEEE Trans. Automatic Control 1974: 19: 716-23.
20. Parker HG, Kim LV, Sutter NB et al. Genetic structure of the purebred domestic dog. Science 2004: 304: 1160-4.
21. Ostrander EA, Wayne RK. The canine genome. Genome Res 2005: 15: 1706-16.
22. Short AD, Kennedy LJ, Barnes A et al. Hardy weinberg expectations in canine breeds: implications for genetic studies. J Hered 2007: 98: 445-51.
23. Franchimont D, Vermeire S, El Housni H et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004: 53: 987-92.
24. Arbour NC, Lorenz E, Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000: 25: 187-91.
25. Torok HP, Glas J, Tonenchi L, Mussack T, Folwaczny C. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 2004: 112: 85-91.
26. Sutter NB, Eberle MA, Parker HG et al. Extensive and breed-specific linkage disequilibrium in Canis familiaris. Genome Res 2004: 14: 2388-96.
27. Lindblad-Toh K, Wade CM, Mikkelsen TS et al. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 2005: 438: 803-19.
28. Chakravarti A. Population genetics-making sense out of sequence. Nat Genet 1999: 21 (1 Suppl): 56-60.
29. Schultz J, Milpetz F, Bork P, Ponting CP. SMART, a simple modular architecture research tool: identification of signaling domains. Proc Natl Acad Sci U S A 1998: 95: 5857-64.
30. Letunic I, Doerks T, Bork P. SMART 6: recent updates and new developments. Nucleic Acids Res 2009: 37: D229-32.
31. McEwan PA, Scott PG, Bishop PN, Bella J. Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans. J Struct Biol 2006: 155: 294-305.
32. Lodes MJ, Cong Y, Elson CO et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004: 113: 1296-306.
33. Lunardi C, Bason C, Dolcino M et al. Antiflagellin antibodies recognize the autoantigens Toll-Like Receptor 5 and Pals 1-associated tight junction protein and induce monocytes activation and increased intestinal permeability in Crohn's disease. J Intern Med 2009: 265: 250-65.
34. Hayashi F, Smith KD, Ozinsky A et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001: 410: 1099-103.
35. Xicohtencatl-Cortes J, Lyons S, Chaparro AP et al. Identification of proinflammatory flagellin proteins in supernatants of Vibrio cholerae O1 by proteomics analysis. Mol Cell Proteomics 2006: 5: 2374-83.
36. Cerquetella M, Spaterna A, Laus F et al. Inflammatory bowel disease in the dog: differences and similarities with humans. World J Gastroenterol 2010: 16: 1050-6.
37. Allenspach K, House A, Smith K et al. Evaluation of mucosal bacteria and histopathology, clinical disease activity and expression of Toll-like receptors in German Shepherd dogs with chronic enteropathies. Vet Microbiol 2010: 146: 326-35.
38. Stanislawowski M, Wierzbicki PM, Golab A et al. Decreased Toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients. J Physiol Pharmacol 2009: 60 (Suppl 4): 71-5.
39. Netea MG, van der Leij F, Drenth JP et al. Chronic yersiniosis due to defects in the TLR5 and NOD2 recognition pathways. Neth J Med 2010: 68: 310-5.